Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
These OTC Securities Reported The Most Trading Volume In January – With Possible Sustained Interest In International Operators
Tickers BNPQY CYDY EEENF ETHE
Tags Benzinga SRUUF SMURF
From Benzinga
Why Are Seagen Shares Sinking Today?
Tickers GSK MRK RHHBY SGEN
Tags News Guidance why it's moving
From Benzinga
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
Tickers ABBV ACLX ALNY AMGN
Tags QGEN SEC RARE
From Benzinga
Cathie Wood's Ark Invest Sheds Stake In This Large-Cap Pharma Ahead Of Earnings
Tickers ARKG BNTX MRK PFE
Tags MRK BNTX Cathie Wood
From Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Tickers ABMD ARWR BIIB BMY
Tags SYRS DGX IBB
From Benzinga
Roche Expects Slower FY22 Sales Growth On Lower Demand For COVID-19 Tests
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHVF General News
From Benzinga
Novartis Expects FY22 Sales, Profit Growth; Sandoz Review Continues
Tickers NVS RHHBF RHHBY RHHVF
Tags RHHBF Biotech Briefs
From Benzinga
Biogen Exercises Option To Participate Developing Genentech's Bispecific Antibody, Mosunetuzumab
Tickers BIIB RHHBF RHHBY RHHVF
Tags Health Care RHHBY Benzinga
From Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
Tickers ABBV ABMD AMLX ARWR
Tags Small Cap TWST MRNA
From Benzinga
FDA Approves First Injectable Eye Medicine For Vision Loss Disorder - Genentech's Vabysmo
Tickers RHHBF RHHBY RHHVF
Tags Health Care RHHBY Benzinga
From Benzinga
Genentech's Evrysdi Application Under FDA Priority Review For Use In Babies Below 2 Months
Tickers RHHBF RHHBY RHHVF
Tags RHHBF RHHVF Briefs
From Benzinga
These OTC Securities Had the Most Trading Activity in December
Tickers ADDYY AKZOY BNPQY CYDVF
Tags NVNXF FNMA BNPQY
From Benzinga
3 Clinical Trials to Watch in the First Half of 2022
Tickers ABBV ARNA BIIB JPM
Tags JPM ABBV RHHBY
From Motley Fool
2 Risky Growth Stocks That Could Make You Filthy Rich
Tickers AZN BGNE JPM LPTX
Tags Recent Press Releases SGEN LPTX
From Motley Fool
Where Will Biogen Be in 5 Years?
Tickers BIIB NVS RHHBY SAGE
Tags NVS Market News RHHBY
From Motley Fool
Medicare pulls back on coverage of an Alzheimer’s drug
Tickers BIIB LLY RHHBY
Tags RHHBY BIIB LLY
From MarketWatch
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
Tickers BIIB ESALF ESALY LLY
Tags RHHVF Government General
From Benzinga
Why Shares of ImmunoGen Jumped 20.3% in December
Tickers IMGN RHHBY
Tags IMGN RHHBY Market News
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates
Tickers ALNY ETON IBB NVS
Tags Top Stories ALNY XERS
From Benzinga
Why Lineage Cell Therapeutics Zoomed Higher Today
Tickers LCTX RHHBY
Tags LCTX RHHBY Market News
From Motley Fool
Lineage, Genentech Ink Cell Therapy Licensing Pact For Ocular Diseases
Tickers LCTX RHHBF RHHBY RHHVF
Tags Movers Trading Ideas Small Cap
From Benzinga
These OTC Securities Had the Most Trading Activity in November
Tickers ADDYY AYRWF BNPQY ETHE
Tags News Market News IPIX
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
Tickers ASRT ATRS BIIB CALT
Tags KYMR XFOR Buybacks
From Benzinga
Novartis Launches New Share Buyback Program Of Up To $15B
Tickers NVS RHHBF RHHBY RHHVF
Tags Market News NVS why it's moving
From Benzinga
After Roche Walks Away, Atea Puts Break On Late-Stage COVID-19 Oral Antiviral Trial
Tickers AVIR RHHBF RHHBY RHHVF
Tags Market News Phase 2 Trial News
From Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
Tickers RHHBF RHHBY RHHVF
Tags Health Care ASH21 Trading Ideas
From Benzinga
The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks
Tickers APTO ATRA AZN BLU
Tags Biotech FATE SNSE
From Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
Tickers RHHBF RHHBY RHHVF
Tags Phase 2 Trial News Market News
From Benzinga
The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More
Tickers ABBV ALLO ARGX AZN
Tags EGRX RHHBY CLLS
From Benzinga
Infinity Pharma Shares Updated Eganelisib Combo Therapy In Breast Cancer Trial
Tickers BMY INFI RHHBF RHHBY
Tags Market News Phase 2 Trial News
From Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.